Presence of plasmid pA15 correlates with prevalence of constitutive MLSB resistance in group A streptococcal isolates at a university hospital in southern Taiwan

Journal of Antimicrobial Chemotherapy

Volumn 59, Issue 6, 2007, Pages 1167-1170

  Liu, Yi Fang ^a   Wang, Chih Hung ^a   Janapatla, Rajendra Prasad ^a   Fu, Hsiu Mei ^a   Wu, Hsiu Mei ^a   Wu, Jiunn Jong ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Clindamycin; Erythromycin; Group A streptococci; PFGE; Plasmids

Indexed keywords

ERYTHROMYCIN; LINCOSAMIDE; MACROLIDE; MIKAMYCIN B; NOVOBIOCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM COLONY; BACTERIUM ISOLATE; CLONE; CONTROLLED STUDY; ELECTROPORATION; HYBRIDIZATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; PLASMID; POLYMERASE CHAIN REACTION; PREVALENCE; PULSED FIELD GEL ELECTROPHORESIS; STREPTOCOCCUS GROUP A; STREPTOCOCCUS GROUP C; TAIWAN; UNIVERSITY HOSPITAL;

ANTI-BACTERIAL AGENTS; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; ERYTHROMYCIN; GENES, BACTERIAL; HOSPITALS, UNIVERSITY; MICROBIAL SENSITIVITY TESTS; PLASMIDS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STREPTOCOCCUS PYOGENES; STREPTOGRAMIN GROUP B; TAIWAN; TRANSFORMATION, BACTERIAL;

EID: 34447567041     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkm106     Document Type: Article

References (14)

1. Hsueh PR, Shyr JM, Wu JJ. Decreased erythromycin use after antimicrobial reimbursement restriction for undocumented bacterial upper respiratory tract infections significantly reduced erythromycin resistance in Streptococcus pyogenes in Taiwan. Clin Infect Dis 2005; 40 903-5.
2. Yan JJ, Wu HM, Huang AH et al. Prevalence of polyclonal mefA containing isolates among erythromycin-resistant group A streptococci in southern Taiwan. J Clin Microbiol 2000; 38: 2475-9.
3. Leclercq R. Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications. Clin Infect Dis 2002; 34: 482-92.
4. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Sixteenth Informational Supplement M100-S16. CLSI, Wayne, PA, USA, 2006.
5. Amezaga MR, Carter PE, Cash P et al. Molecular epidemiology of erythromycin resistance in Streptococcus pneumoniae isolates from blood and noninvasive sites. J Clin Microbiol 2002; 40: 3313-8.
6. Chiang-Ni C, Wang CH, Tsai PJ et al. Streptococcal pyrogenic exotoxin B causes mitochondria damage to polymorphonuclear cells preventing phagocytosis of group A streptococcus. Med Microbiol Immunol 2006; 195: 55-63.
7. Schalen C, Gebreselassie D, Stahl S. Characterization of an erythromycin resistance (erm) plasmid in Streptococcus pyogenes. APMIS 1995; 103: 59-68.
8. Sambrook J, Russell D. Molecular Cloning: A Laboratory Handbook. Third Edition. Cold Spring Harbor, NY, USA: Cold Spring Harbor Laboratory Press, 2001.
9. Beall B, Facklam R, Thompson T. Sequencing emm-specific PCR products for routine accurate typing of group A streptococci. J Clin Microbiol 1996; 34: 953-8.
10. Ceglowski P, Lurz R, Alonso JC. Functional analysis of pSM19035-derived replicons in Bacillus subtilis. FEMS Microbiol Lett 1993; 109 145-50.
11. Ceglowski P, Alonso JC. Gene organization of the Streptococcus pyogenes plasmid pDB101: Sequence analysis of the orf eta-copS region. Gene 1994; 145: 33-9.
12. Zielenkiewicz U, Ceglowski P. The toxin-antitoxin system of the streptococcal plasmid pSM19035. J Bacteriol 2005; 187: 6094-105.
13. Cresti S, Lattanzi M, Zanchi A et al. Resistance determinants and clonal diversity in group A streptococci collected during a period of increasing macrolide resistance. Antimicrob Agents Chemother 2002; 46: 1816-22.
14. Perez-Trallero E, Marimon JM, Montes M et al. Clonal differences among erythromycin-resistant Streptococcus pyogenes in Spain. Emerg Infect Dis 1999; 5: 235-40.